array:23 [ "pii" => "S2173574309701315" "issn" => "21735743" "doi" => "10.1016/S2173-5743(09)70131-5" "estado" => "S300" "fechaPublicacion" => "2009-11-01" "aid" => "70131" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "copyrightAnyo" => "2009" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "edi" "cita" => "Reumatol Clin. 2009;5:241-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1707 "formatos" => array:3 [ "EPUB" => 43 "HTML" => 1253 "PDF" => 411 ] ] "itemSiguiente" => array:18 [ "pii" => "S2173574309701327" "issn" => "21735743" "doi" => "10.1016/S2173-5743(09)70132-7" "estado" => "S300" "fechaPublicacion" => "2009-11-01" "aid" => "70132" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2009;5:244-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2152 "formatos" => array:3 [ "EPUB" => 42 "HTML" => 1432 "PDF" => 678 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "The joint hypermobility syndrome in a Cuban juvenile population" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "244" "paginaFinal" => "247" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Síndrome de hipermovilidad articular en una población juvenil cubana" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Francisco M. Menéndez Alejo, Damaris Díaz Lazaga, Verena Torrez Cárdenas, Vicente Martínez Rodríguez" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Francisco M." "apellidos" => "Menéndez Alejo" ] 1 => array:2 [ "nombre" => "Damaris" "apellidos" => "Díaz Lazaga" ] 2 => array:2 [ "nombre" => "Verena" "apellidos" => "Torrez Cárdenas" ] 3 => array:2 [ "nombre" => "Vicente" "apellidos" => "Martínez Rodríguez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574309701327?idApp=UINPBA00004M" "url" => "/21735743/0000000500000006/v1_201305061600/S2173574309701327/v1_201305061600/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2173574309701303" "issn" => "21735743" "doi" => "10.1016/S2173-5743(09)70130-3" "estado" => "S300" "fechaPublicacion" => "2009-11-01" "aid" => "70130" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "edb" "cita" => "Reumatol Clin. 2009;5:240" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1598 "formatos" => array:3 [ "EPUB" => 49 "HTML" => 1019 "PDF" => 530 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Reumatología Clínica. A promising future to walk together" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "240" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Reumatología Clínica. Un futuro prometedor para recorrer juntos" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jordi Gratacós Masmitjà" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jordi" "apellidos" => "Gratacós Masmitjà" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574309701303?idApp=UINPBA00004M" "url" => "/21735743/0000000500000006/v1_201305061600/S2173574309701303/v1_201305061600/en/main.assets" ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Economic evaluation of health interventions: the opportunity cost of not evaluating" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "241" "paginaFinal" => "243" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Jaume Puig-Junoy, Juan Oliva" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Jaume" "apellidos" => "Puig-Junoy" "email" => array:1 [ 0 => "jaume.puig@upf.edu" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Juan" "apellidos" => "Oliva" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Centro de Investigación en Economía y Salud (CRES-UPF), Universitat Pompeu Fabra, Barcelona, Spain" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Departamento de Análisis Económico, Facultad de Ciencias Jurídicas y Sociales de Toledo, Universidad de Castilla-La Mancha, Investigador afiliado al CRES, Toledo, Spain" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Evaluación económica de intervenciones sanitarias: el coste de oportunidad de no evaluar" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:15 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluación económica de medicamentos: experiencias y vías de avance. Una visión complementaria" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Oliva" 1 => "E. Bernal" 2 => "J. Puig-Junoy" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Gac Sanit" "fecha" => "2008" "volumen" => "22" "paginaInicial" => "358" "paginaFinal" => "361" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18755088" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluación económica y la toma de decisiones en salud. El papel de la evaluación económica en la adopción y difusión de tecnologías sanitarias. Informe SESPAS 2008" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Oliva" 1 => "F. Antoñanzas" 2 => "O. Rivero-Arias" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Gac Sanit" "fecha" => "2008" "volumen" => "1" "paginaInicial" => "137" "paginaFinal" => "142" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Anell" 1 => "U. Persson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10198-005-0301-6" "Revista" => array:6 [ "tituloSerie" => "Eur J Health Econ" "fecha" => "2005" "volumen" => "6" "paginaInicial" => "274" "paginaFinal" => "279" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15968561" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Available from: <a class="elsevierStyleInterRef" href="http://www.tlv.se/in-english/documents/">http://www.tlv.se/in-english/documents/</a>." ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Implementing accountability for reasonableness –the case of pharmaceutical reimbursement in Sweden" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S. Jansson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Health Economics, Policy and Law" "fecha" => "2007" "volumen" => "2" "paginaInicial" => "153" "paginaFinal" => "171" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients’ notes, and interviews" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T.A. Sheldon" 1 => "N. Cullum" 2 => "D. Dawson" 3 => "A. Lankshear" 4 => "K. Lowson" 5 => "I. Watt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.329.7473.999" "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2004" "volumen" => "329" "paginaInicial" => "999" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15514342" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "National Institute for Clinical Excellence and its value judgments" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Rawlins" 1 => "A.J. Culyer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.329.7459.224" "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "2004" "volumen" => "329" "paginaInicial" => "224" "paginaFinal" => "227" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15271836" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "De la utilidad de los medicamentos al valor terapéutico añadido y a la relación coste-efectividad incremental" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Puig-Junoy" 1 => "S. Peiró" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Salud Pública" "fecha" => "2009" "volumen" => "83" "paginaInicial" => "59" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19495489" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Una propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias: ¿ha llegado el momento?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. López-Bastida" 1 => "J. Oliva" 2 => "F. Antoñanzas" 3 => "A. García-Altés" 4 => "R. Gisbert" 5 => "J. Mar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Econ Salud" "fecha" => "2008" "volumen" => "21" "paginaInicial" => "1" "paginaFinal" => "2" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Critical appraisal of pharmacoeconomic Studies comparing TNF-α antagonists for rheumatoid arthritis treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Barbieri" 1 => "M. Drummond" 2 => "J. Puig-Junoy" 3 => "M.A. Casado" 4 => "F.J. Ballina" 5 => "P. Blasco" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Expert Rev Pharmacoeconomics Outcomes Res" "fecha" => "2007" "volumen" => "7" "paginaInicial" => "613" "paginaFinal" => "626" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparación de leflunomida y metotrexato subcutáneo en el tratamiento de la artritis reumatoide: una aproximación basada en el número de pacientes que es necesario tratar" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A.J. García Ruiz" 1 => "A.C. Montesinos Gálvez" 2 => "L. Pérez Costillas" 3 => "P. Rebollo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.reuma.2008.11.007" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2009" "volumen" => "5" "paginaInicial" => "66" "paginaFinal" => "70" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21794646" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Galván J. Estudio coste-efectividad de leflunomida frente a metotrexato. Reumatol Clin. 2009 [in press]." ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "López Bastida J, Oliva J, Antoñanzas F, García-Altés A, Gisbert R, Mar J, et al. Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias. Madrid: Plan Nacional para el SNS del MSC. Servicio de Evaluación del Servicio Canario de la Salud; 2008. Informes de Evaluación de Tecnologías Sanitarias: SESCS No 2006/22." ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Health economics guidelines –Similarities, differences and some implications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K. Hjelmgren" 1 => "F. Berggren" 2 => "F. Andersson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1046/j.1524-4733.2001.43040.x" "Revista" => array:6 [ "tituloSerie" => "Value in Health" "fecha" => "2001" "volumen" => "4" "paginaInicial" => "225" "paginaFinal" => "250" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11705185" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Economic evaluation and decision-makers" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Drummond" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:4 [ "titulo" => "The Elgar companion to health economics" "paginaInicial" => "537" "paginaFinal" => "545" "serieFecha" => "2006" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000000500000006/v1_201305061600/S2173574309701315/v1_201305061600/en/main.assets" "Apartado" => array:4 [ "identificador" => "17335" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000000500000006/v1_201305061600/S2173574309701315/v1_201305061600/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574309701315?idApp=UINPBA00004M" ]
Journal Information
Vol. 5. Issue 6.
Pages 241-243 (November - December 2009)
Vol. 5. Issue 6.
Pages 241-243 (November - December 2009)
Full text access
Economic evaluation of health interventions: the opportunity cost of not evaluating
Evaluación económica de intervenciones sanitarias: el coste de oportunidad de no evaluar
Visits
4922
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
J. Oliva, E. Bernal, J. Puig-Junoy.
Evaluación económica de medicamentos: experiencias y vías de avance. Una visión complementaria.
Gac Sanit, 22 (2008), pp. 358-361
[2.]
J. Oliva, F. Antoñanzas, O. Rivero-Arias.
Evaluación económica y la toma de decisiones en salud. El papel de la evaluación económica en la adopción y difusión de tecnologías sanitarias. Informe SESPAS 2008.
Gac Sanit, 1 (2008), pp. 137-142
[3.]
A. Anell, U. Persson.
Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?.
Eur J Health Econ, 6 (2005), pp. 274-279
[4.]
Available from: http://www.tlv.se/in-english/documents/.
[5.]
S. Jansson.
Implementing accountability for reasonableness –the case of pharmaceutical reimbursement in Sweden.
Health Economics, Policy and Law, 2 (2007), pp. 153-171
[6.]
T.A. Sheldon, N. Cullum, D. Dawson, A. Lankshear, K. Lowson, I. Watt, et al.
What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients’ notes, and interviews.
BMJ, 329 (2004), pp. 999
[7.]
M. Rawlins, A.J. Culyer.
National Institute for Clinical Excellence and its value judgments.
BMJ, 329 (2004), pp. 224-227
[8.]
J. Puig-Junoy, S. Peiró.
De la utilidad de los medicamentos al valor terapéutico añadido y a la relación coste-efectividad incremental.
Rev Esp Salud Pública, 83 (2009), pp. 59-70
[9.]
J. López-Bastida, J. Oliva, F. Antoñanzas, A. García-Altés, R. Gisbert, J. Mar, et al.
Una propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias: ¿ha llegado el momento?.
Econ Salud, 21 (2008), pp. 1-2
[10.]
M. Barbieri, M. Drummond, J. Puig-Junoy, M.A. Casado, F.J. Ballina, P. Blasco, et al.
Critical appraisal of pharmacoeconomic Studies comparing TNF-α antagonists for rheumatoid arthritis treatment.
Expert Rev Pharmacoeconomics Outcomes Res, 7 (2007), pp. 613-626
[11.]
A.J. García Ruiz, A.C. Montesinos Gálvez, L. Pérez Costillas, P. Rebollo.
Comparación de leflunomida y metotrexato subcutáneo en el tratamiento de la artritis reumatoide: una aproximación basada en el número de pacientes que es necesario tratar.
Reumatol Clin, 5 (2009), pp. 66-70
[12.]
Galván J. Estudio coste-efectividad de leflunomida frente a metotrexato. Reumatol Clin. 2009 [in press].
[13.]
López Bastida J, Oliva J, Antoñanzas F, García-Altés A, Gisbert R, Mar J, et al. Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias. Madrid: Plan Nacional para el SNS del MSC. Servicio de Evaluación del Servicio Canario de la Salud; 2008. Informes de Evaluación de Tecnologías Sanitarias: SESCS No 2006/22.
[14.]
K. Hjelmgren, F. Berggren, F. Andersson.
Health economics guidelines –Similarities, differences and some implications.
Value in Health, 4 (2001), pp. 225-250
[15.]
M. Drummond.
Economic evaluation and decision-makers.
The Elgar companion to health economics, pp. 537-545
Copyright © 2009. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología